KTD-092

KTD-092, a DYRK1A inhibitor, exhibits an IC50 of 22 nM against human DYRK1A. It is applicable in research related to Down syndrome (DS), Alzheimer's disease (AD), autism spectrum disorder (ASD), diabetes, and other neurodegenerative diseases.

Product Specifications

Field of Research

Cell Biology, Signal Transduction

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

13921021 500 ng

C16orf5 Protein Vector (Human) (pPM-C-HA)

View Details

MBS6198295-01 0.1 mL

TGIF2 (TGFB-Induced Factor Homeobox 2) (MaxLight 405)

View Details

MBS6198295-02 5x 0.1 mL

TGIF2 (TGFB-Induced Factor Homeobox 2) (MaxLight 405)

View Details

OACA08437-50UL 50 µL

CSNK1G1 Antibody

View Details

sc-403969-LAC-2 200 µL

AATM Lentiviral Activation Particles (h2)

View Details

orb2945886-01 1 mg

Fladrafinil

View Details